Harness virtual patients and in silico simulation to design faster, smarter clinical trials for digital therapeutics (DTx) and digital biomarker validation.
- Optimize inclusion criteria
- Predict clinical outcomes
- De-risk development
- Align with regulatory expectations
Get to market faster—without compromising on science.
See: Evolution Of Digital Therapeutics (DTx):
Utilizing Clinical Trials, Reverse Translation, And In Silico Methods For Enhanced
Product Lifecycle Management In Chronic Disorders With Episodic Manifestations (CDEM)
Markus A. Dahlem, Brett M. Colbert, Felix M. Schneider, Morgan Craig, Shaheen Lakhan
Poster at International Society for CNS Clinical Trials and Methodology, 2023 Autum Conference. (LINK)
